A Nonneutralizing Anti-HIV Type 1 Antibody Turns into a Broad Neutralizing Antibody When Expressed on the Surface of HIV Type 1-Susceptible Cells. II. Inhibition of HIV Type 1 Captured and Transferred by DC-SIGN
- 1 September 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 22 (9), 874-883
- https://doi.org/10.1089/aid.2006.22.874
Abstract
Previously, we demonstrated that the expression of a nonneutralizing human anti-HIV-1 gp41 scFv on the surface of HIV-1-susceptible cells markedly inhibits HIV-1 replication and HIV-1 envelope-mediated cell–cell fusion. The inhibition is at the level of viral entry, specific for the HIV-1 envelope, and independent of virus tropism. In the previous studies, cell-free viruses of laboratory-adapted HIV-1 strains from subtype B were used to infect human CD4 T cell lines. To further test the effectiveness of this membrane-bound scFv (m-scFv) on HIV-1 infection, in this study, we carried out experiments to determine whether the m-scFv can neutralize infection of primary isolates from various HIV-1 subtypes and whether the m-scFv can neutralize HIV-1 captured and transferred by DC-SIGN on the surface of monocytic cell lines or DCs. We demonstrated that the m-scFv markedly inhibits primary isolates derived from various subtypes and significantly blocks HIV-1 captured and transferred by DC-SIGN on monocytic cell lines and on human DCs. Therefore, a nonneutralizing antibody acts as a broad neutralizing antibody when expressed on the cell surface, which significantly inhibits infection of both cell-free and DC-SIGN-captured and transferred virus. Our studies further point out the potential use of m-scFv as a inhibitor against HIV-1 transmission as well as a tool to dissect the mechanism of HIV-1 entry via DC-SIGN capture and transfer to CD4 T cells.Keywords
This publication has 45 references indexed in Scilit:
- Covert Human Immunodeficiency Virus Replication in Dendritic Cells and in DC-SIGN-Expressing Cells Promotes Long-Term Transmission to LymphocytesJournal of Virology, 2005
- Infection of Specific Dendritic Cells by CCR5-Tropic Human Immunodeficiency Virus Type 1 Promotes Cell-Mediated Transmission of Virus Resistant to Broadly Neutralizing AntibodiesJournal of Virology, 2004
- Self- and Nonself-Recognition by C-Type Lectins on Dendritic CellsAnnual Review of Immunology, 2004
- Capture and Transfer of Simian Immunodeficiency Virus by Macaque Dendritic Cells Is Enhanced by DC-SIGNJournal of Virology, 2002
- A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2001
- High-Efficiency Gene Transfer into Rhesus Macaque Primary T Lymphocytes by Combining 32°C Centrifugation and CH-296-Coated Plates: Effect of Gene Transfer Protocol on T Cell Homing Receptor ExpressionHuman Gene Therapy, 2001
- Construction and Analysis of an Infectious Human Immunodeficiency Virus Type 1 Subtype C Molecular CloneJournal of Virology, 2001
- Distinct but Related Human Immunodeficiency Virus Type 1 Variant Populations in Genital Secretions and BloodAIDS Research and Human Retroviruses, 1996
- Two-Phase Approach for the Expression of High-Affinity Human Anti-Human Immunodeficiency Virus Immunoglobulin Fab Domains inEscherichia coliHybridoma, 1995
- Improved Methods of Retroviral Vector Transduction and Production for Gene TherapyHuman Gene Therapy, 1994